|
US5585344A
(en)
*
|
1984-03-19 |
1996-12-17 |
The Rockefeller University |
Liver-derived receptors for advanced glycosylation endproducts and uses thereof
|
|
US4774321A
(en)
*
|
1986-12-01 |
1988-09-27 |
Massachusetts Institute Of Technology |
DP100 EGF and insulin-binding protein from Drosophila cells
|
|
US5200509A
(en)
*
|
1987-04-06 |
1993-04-06 |
Celtrix Pharmaceuticals, Inc. |
Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
|
|
ATE90690T1
(de)
|
1987-04-06 |
1993-07-15 |
Celtrix Pharma |
Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.
|
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク，インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
|
GB8826451D0
(en)
|
1988-11-11 |
1988-12-14 |
Sandoz Ltd |
Improvements in/relating to organic compounds
|
|
US5571714A
(en)
*
|
1988-12-22 |
1996-11-05 |
Celtrix Pharmaceuticals, Inc. |
Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
|
|
IL92816A0
(en)
|
1988-12-22 |
1990-09-17 |
Biogrowth Inc |
Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides
|
|
US5705157A
(en)
*
|
1989-07-27 |
1998-01-06 |
The Trustees Of The University Of Pennsylvania |
Methods of treating cancerous cells with anti-receptor antibodies
|
|
US5977307A
(en)
*
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
|
WO1992003152A1
(en)
*
|
1990-08-28 |
1992-03-05 |
Chiron Corporation |
New insulin-like growth factor binding protein (igfbp-4)
|
|
GB9300059D0
(en)
|
1992-01-20 |
1993-03-03 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US5262308A
(en)
*
|
1992-01-28 |
1993-11-16 |
Thomas Jefferson University |
Cell lines which constitutively express IGF-1 and IGF-1 R
|
|
US5597563A
(en)
*
|
1992-09-04 |
1997-01-28 |
Beschorner; William E. |
Method induction of antigen-specific immune tolerance
|
|
US5869337A
(en)
*
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
WO1994023034A2
(en)
*
|
1993-04-06 |
1994-10-13 |
Cedars-Sinai Medical Center |
Variant insulin-like growth factor i receptor subunits and methods for use thereof
|
|
WO1995019570A1
(en)
*
|
1994-01-14 |
1995-07-20 |
Genentech, Inc. |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
|
US5532159A
(en)
*
|
1994-04-01 |
1996-07-02 |
The Ohio State University |
Monoclonal antibody to canine placental oncofetal protein for detecting cancer
|
|
US5597700A
(en)
*
|
1994-04-28 |
1997-01-28 |
California Research, Llc |
Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
|
|
WO1996000084A1
(en)
*
|
1994-06-24 |
1996-01-04 |
Torchilin Vladimir P |
Use of autoantibodies for tumor therapy and prophylaxis
|
|
US5939269A
(en)
*
|
1994-12-28 |
1999-08-17 |
The Regents Of The University Of California |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
|
DE69536015D1
(de)
|
1995-03-30 |
2009-12-10 |
Pfizer Prod Inc |
Chinazolinone Derivate
|
|
JPH11507535A
(ja)
|
1995-06-07 |
1999-07-06 |
イムクローン システムズ インコーポレイテッド |
腫瘍の成長を抑制する抗体および抗体フラグメント類
|
|
US6084085A
(en)
*
|
1995-11-14 |
2000-07-04 |
Thomas Jefferson University |
Inducing resistance to tumor growth with soluble IGF-1 receptor
|
|
AUPN999096A0
(en)
|
1996-05-22 |
1996-06-13 |
Northstar Biologicals Pty Ltd |
Peptides, antibodies, vaccines & uses thereof
|
|
US5798266A
(en)
*
|
1996-08-27 |
1998-08-25 |
K-Quay Enterprises, Llc |
Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
|
|
US6071891A
(en)
*
|
1996-11-22 |
2000-06-06 |
Regents Of The University Of Minnesota |
Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition
|
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
CA2299471C
(en)
*
|
1997-08-15 |
2007-12-18 |
Cephalon Inc. |
Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
|
|
ZA200007412B
(en)
*
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
|
US6875741B2
(en)
*
|
1998-09-02 |
2005-04-05 |
Renuka Pillutla |
Insulin and IGF-1 receptor agonists and antagonists
|
|
SK4272001A3
(en)
*
|
1998-10-05 |
2003-02-04 |
Pharmexa As |
Methods for therapeutic vaccination
|
|
EP1006184A1
(en)
*
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
|
|
US6316462B1
(en)
*
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
|
CA2409991A1
(en)
|
2000-05-24 |
2001-11-29 |
Imclone Systems Incorporated |
Bispecific immunoglobulin-like antigen binding proteins and method of production
|
|
US20030165502A1
(en)
*
|
2000-06-13 |
2003-09-04 |
City Of Hope |
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
|
|
US7329745B2
(en)
*
|
2000-06-13 |
2008-02-12 |
City Of Hope |
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
|
|
US7071160B2
(en)
*
|
2000-06-15 |
2006-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Insulin-like growth factor-binding protein
|
|
US8153121B2
(en)
*
|
2000-10-06 |
2012-04-10 |
Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center |
Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
|
|
ME00502B
(me)
|
2001-01-05 |
2011-10-10 |
Amgen Fremont Inc |
Antitjela za insulinu sličan receptor faktora i rasta
|
|
WO2002072780A2
(en)
*
|
2001-03-14 |
2002-09-19 |
Genentech, Inc. |
Igf antagonist peptides
|
|
US20040116330A1
(en)
*
|
2001-04-27 |
2004-06-17 |
Kenichiro Naito |
Preventive/therapeutic method for cancer
|
|
US7666414B2
(en)
*
|
2001-06-01 |
2010-02-23 |
Cornell Research Foundation, Inc. |
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
|
|
US20040214898A1
(en)
*
|
2001-11-29 |
2004-10-28 |
Steiner Mitchell S. |
Methods for treating hot flashes
|
|
US7553485B2
(en)
*
|
2002-01-18 |
2009-06-30 |
Pierre Fabre Medicament |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
|
US7241444B2
(en)
*
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
|
SI1461359T1
(sl)
|
2002-01-18 |
2007-06-30 |
Pf Medicament |
Nova anti IGF-IR protitelesa in njihova uporaba
|
|
EP1506286B1
(en)
|
2002-05-24 |
2014-03-19 |
Merck Sharp & Dohme Corp. |
Neutralizing human anti-igfr antibody
|
|
US8034904B2
(en)
*
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
AU2003244817B2
(en)
*
|
2002-06-28 |
2010-08-26 |
Domantis Limited |
Antigen-binding immunoglobulin single variable domains and dual-specific constructs
|
|
JP5138867B2
(ja)
*
|
2002-08-01 |
2013-02-06 |
イミューノメディクス、インコーポレイテッド |
α−フェトタンパク質Ｉｍｍｕ３１抗体および融合タンパク質ならびにその使用方法
|
|
US20040102360A1
(en)
*
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
|
PL378812A1
(pl)
|
2003-02-13 |
2006-05-29 |
Pfizer Products Inc. |
Zastosowania przeciwciał przeciw receptorowi insulinopodobnego czynnika wzrostowego I
|
|
JP2007528201A
(ja)
*
|
2003-03-14 |
2007-10-11 |
ファルマシア・コーポレーション |
癌治療のためのｉｇｆ−ｉ受容体に対する抗体
|
|
ES2383014T3
(es)
|
2003-04-02 |
2012-06-15 |
F. Hoffmann-La Roche Ag |
Anticuerpos contra el factor I de crecimiento similar a insulina y usos de los mismos
|
|
CA2524305C
(en)
|
2003-05-01 |
2015-12-08 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
AR046071A1
(es)
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
|
WO2005014618A2
(en)
*
|
2003-08-08 |
2005-02-17 |
Immunomedics, Inc. |
Bispecific antibodies for inducing apoptosis of tumor and diseased cells
|
|
DE602004029581D1
(de)
*
|
2003-08-13 |
2010-11-25 |
Pfizer Prod Inc |
Modifizierte humane igf-1r antikörper
|
|
JPWO2005027970A1
(ja)
*
|
2003-09-24 |
2007-11-15 |
協和醗酵工業株式会社 |
癌治療用医薬
|
|
TW200526684A
(en)
*
|
2003-11-21 |
2005-08-16 |
Schering Corp |
Anti-IGFR1 antibody therapeutic combinations
|
|
US20050164970A1
(en)
*
|
2003-12-22 |
2005-07-28 |
University Of Kansas Medical Center |
Method for treating prostate cancer using siRNA duplex for androgen receptor
|
|
WO2005082415A2
(en)
|
2004-02-25 |
2005-09-09 |
Dana Farber Cancer Institute, Inc. |
Inhibitors of insulin-like growth factor receptor-1 for inhibiting tumor cell growth
|
|
CA2560305C
(en)
*
|
2004-03-19 |
2016-07-05 |
Imclone Systems Incorporated |
Human anti-epidermal growth factor receptor antibody
|
|
KR20080019733A
(ko)
|
2004-07-16 |
2008-03-04 |
화이자 프로덕츠 인코포레이티드 |
항-아이지에프-1알 항체를 사용하는 비-혈액학적악성종양에 대한 조합 치료
|
|
EP1786918A4
(en)
|
2004-07-17 |
2009-02-11 |
Imclone Systems Inc |
NEW BISPECIFIC ANTIBODY TETRAVALENT
|
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
US20070010537A1
(en)
*
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
|
PT1828249E
(pt)
|
2004-12-03 |
2011-02-25 |
Schering Corp |
Biomarcadores para a pré-selecção de pacientes para terapêutica anti-igf1r
|
|
WO2006068829A1
(en)
*
|
2004-12-21 |
2006-06-29 |
Alcon, Inc. |
Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (lox) and lox-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
KR20070120156A
(ko)
*
|
2005-04-15 |
2007-12-21 |
이뮤노젠 아이엔씨 |
종양에서 이종 또는 혼성 세포 집단의 제거 방법
|
|
CA2612449A1
(en)
*
|
2005-06-17 |
2006-12-28 |
Imclone Systems Incorporated |
Receptor antagonists for treatment of metastatic bone cancer
|
|
WO2007000328A1
(en)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
|
US20070009970A1
(en)
*
|
2005-07-08 |
2007-01-11 |
Predicant Biosciences, Inc. |
Biological patterns for diagnosis and treatment of cancer
|
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
AU2006290433B2
(en)
|
2005-08-26 |
2012-06-07 |
Roche Glycart Ag |
Modified antigen binding molecules with altered cell signaling activity
|
|
DK1979001T3
(da)
*
|
2005-12-13 |
2012-07-16 |
Medimmune Ltd |
Bindingsproteiner, der er specifikke for insulinlignende vækstfaktorer og anvendelser deraf
|